CareFusion

From Wikipedia, the free encyclopedia
CareFusion Corporation
Type Public
Traded as NYSE: CFN
S&P 500 Component
Industry Medical Technology
Founded 2009
Headquarters San Diego, CA U.S.
Area served Worldwide
Key people Kieran Gallahue<br/ >(Chairman and CEO)<br/ >Jim Hinrichs <br/ >(Chief Financial Officer)
Products Medical devices
Clinical services
Employees 15,000 (2012)
Website carefusion.com

CareFusion is a global, medical technology corporation serving the health care industry. The company specializes in two areas: reducing medication errors and prevention of health care-associated infections. The company manufactures health care technologies including Alaris IV pumps, Pyxis automated dispensing and patient identification systems, AirLife, AVEA and LTV series of ventilators and respiratory products, ChloraPrep skin prep products, MedMined services for infection surveillance, V. Mueller and Snowden-Pencer surgical instruments and a line of products that support interventional medicine.[1] CareFusion employs approximately 15,000 people worldwide.

In January 2014 United States Department of Justice accepted a $40.6 million fine from CareFusion to withdraw its allegations that Charles Denham had accepted USD $11.6 million from this company to compromise his role as co-chair of the Safe Practices Committee at the National Quality Forum to recommend, promote and arrange for the purchase of that company's products.[2]

History

CareFusion completed its spin-off from Cardinal Health on August 31, 2009. Businesses that were part of the Clinical and Medical Products segment of Cardinal Health were spun off to create CareFusion. CareFusion began publicly trading on the New York Stock Exchange on September 1, 2009,[3] with former CEO David Schlotterbeck. The company’s family of products includes brands used by more than 25,000 health care customers worldwide,[4] including hospitals, ambulatory surgery centers, long-term care facilities, outpatient clinics, governments and insurance providers.

On May 17, 2010, CareFusion acquired Medegen, Inc. for US$ 225 million in cash. This was the company’s first completed acquisition, and added needleless access connectors and administration sets that deliver intravenous (IV) medication to patients to their portfolio of products.

On February 1, 2011, Kieran T. Gallahue was named CareFusion's chairman and CEO. Prior to this role, he was the president and CEO of ResMed, a medical device company that focuses on sleep-related respiratory disorders.

In April 2012, CareFusion sold the Nicolet operating unit to Natus Medical Incorporated for $58 million.

On July 7, 2012, CareFusion acquired U.K. Medical Limited, a distributor of medical products to the National Health Service and private health care sector in the United Kingdom.

In October 2012, CareFusion acquired Intermed Equipamento Medico Hospitalar Ltda, a privately held, respiratory technologies company based in São Paulo, Brazil. Intermed designs, manufactures and markets ventilators and respiratory care devices for infant, pediatric and adult patients that are used in hospitals in Brazil and Latin America.

On November 18 2013, CareFusion acquired Vital Signs Inc., a medical device manufacturing business, with the exception of European operations from GE Healthcare.

In 2013, CareFusion bought 40% of the Israeli company Caesarea Medical Electronics.[5]

Lawsuit

In January 2014 United States Department of Justice accepted a $40.6 million fine from CareFusion to withdraw its allegations that Charles Denham had accepted USD $11.6 million from this company to compromise his role as co-chair of the Safe Practices Committee at the National Quality Forum to recommend, promote and arrange for the purchase of that company's products.[6]

The state of Pennsylvania is to receive some of the settlement money.[7]

Business Segments

CareFusion currently has two business segments:

Medical Systems

This provides the following products:

  • Dispensing: Pyxis medication and supply automation products
  • Infusion: Alaris Infusion pump and infusion safety products
  • Respiratory: AVEA and LTV series of ventilators and AirLife respiratory accessories

Procedural Solutions

This provides the following products and services:

  • Infection Prevention and Surveillance: ChloraPrep CHG patient preoperative skin preparation MaxPlus needleless connectors and MedMined infection surveillance services
  • Medical Specialties: V. Mueller and Snowden-Pencer surgical instruments, IMPRESS instrument tracking software, AVAmax and AVAflex brands for vertebroplasty and kyphoplasty procedures, Nicolet neurodiagnostic instruments and PleurX catheter drainage products[8]

References

  1. ↑ About CareFusion.
  2. ↑
  3. ↑ CareFusion Annual Report, 2010.
  4. ↑ CareFusion Investor Relations
  5. ↑ The boycott movement is losing the battle - for now
  6. ↑
  7. ↑ Campisi, Jon (13 January 2014). "Pa. to share in $40.1 million CareFusion settlement over ChloraPrep off-label marketing allegations". pennrecord.com. Retrieved 24 January 2014. 
  8. ↑ CareFusion Fact Sheet.

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.